Symbol
CRISPR Therapeutics AG
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$36.29
Current price of the stock
$2M
Trading volume of the stock
$3.1B
Market capitalization of the company
Mid Cap
Category of market capitalization
20.63%
Long-term growth mean estimate
4.12
Mean analyst rating
120.92%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
21.64
Current ratio
100.00%
Gross profit margin
-18294.02%
Operating profit margin
-18294.02%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-14130.56%
Pretax profit margin
-14276.08%
Net profit margin
-4.43%
Measures profitability relative to shareholders' equity
-4.43%
ROE excluding intangible assets
-3.81%
Measures profitability relative to total assets
-4.43%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-12.91
Measures valuation relative to earnings
-6.82
P/E based on future earnings estimates
15.25
Measures valuation relative to sales
1.60
Measures valuation relative to book value
-12.66
Measures valuation relative to operating cash flow
-11.97
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
